chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dizzy; nauseous; vertigo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:. The reporter is the patient.  A 67-year-old female patient received PF-06928316 (ABRYSVO), on 27Aug2023 at 17:00 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VERTIGO (non-serious) with onset Aug2023, 7 hrs after the suspect product(s) administration, outcome "unknown"; DIZZINESS (non-serious) with onset 28Aug2023, outcome "not recovered", described as "dizzy"; NAUSEA (non-serious) with onset 28Aug2023, outcome "unknown", described as "nauseous". The event "vertigo" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had the Rsv Abrysvo injection on Sunday (27Aug2023) 5:00 pm and woke up the following Monday (28Aug2023) morning dizzy & nauseous. It is now 4 days later and the patient continue to wake become dizzy when moving out of bed and moving my head. The patient said she seemed to be having an adverse reaction to the vaccine. The patient had vertigo and sent the patient to the ER to get a CT scan. She was currently waiting to speak to the doctor in the ER. She read somewhere online that there were small cases of meningitis. She can move her neck so its not meningitis.   The information on the batch/lot number for PF-06928316 has been requested and will be submitted if and when received.
Patient complained of shoulder pain/stiffness and mild edema of shoulder ~1-2 weeks after receiving flu vaccination.
Client received vaccines on 10-10-12. Father called on 10-12-12 and states client has had a reaction to the vaccines. Father states that client has a small knot and redness the size of a baseball on the fatty part of his right arm. Father denies client experience of fever, SOB, DIB. Father states client c/o a lot of pain in his R arm. Father called back on 10-19-12 asking for school excuse and states prior symtoms have resolved.
This dose did not make me feel sick, just high; Severe brain fog; Body high; Dilated pupils; Flushed skin; Acting "silly"; This is a spontaneous report received from a contactable consumer (patient). This is the first of three reports. A 27-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 19Mar2021 at 09:00 (at the age of 27-year-old) as a dose 2, single for COVID-19 immunization. Medical history included allergic to kiwi fruits and severe allergic reaction to an unknown dye found in LO LOESTRIN Fe. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL FE 1/20) and naproxen (ALEVE), for unknown indications from unknown dates. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunisation and felt sick. The patient frequently had adverse reactions to medicines and had previously received diazepam (VALIUM) which made her extremely hyper. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Mar2021 at 15:00, the patient felt like she ate a strong dose of marijuana a few hours after vaccination and no one she talked to had an effect like this. This is around the time that she had felt sick when she received the first dose. This dose did not make her feel sick but she was just high. Her father said he had the same reaction, though. Symptoms included severe brain fog, body high, dilatedpupils/flushed skin, acting silly for lack of a better word. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events feeling high, severe brain fog, body high, dilated pupils, flushed skin, acting silly. The clinical outcome of the events feeling high, severe brain fog, body high, dilated pupils, flushed skin, acting silly was recovered with lasting effects on an unknown date on Mar2021.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Myocarditis and pericarditis. Felt mild chest pain that subsided after a couple hours. Kept in hospital for 3 nights to do testing and to make sure I was recovering. Troponin level was high (I think 17) at time of admittance and fell after.
Vaccinated with Pfizer vaccines x 2 in March and April 2021.  Symptoms started 12/18/2021 - fatigue, myalgia, sore throat.
Patient was initially administered Prevnar when he needed a Hepatitis A vaccine. The nurse notified the doctor, Hepatitis A was given. No adverse events, no treatment necessary.
Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A22A) for COVID-19 vaccination.     It was reported patient had no allergies to medications, food and other products and did not have COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  The patient's past medical history included Stomach discomfort (before getting the vaccine), Faint (patient fainted in the past, due to vertigo) and Vertigo (patient fainted in the past, due to vertigo). Concurrent medical conditions included Blood pressure high (15 years ago and patient did not knowhow was her blood pressure.). Concomitant products included AMLODIPINE, LISINOPRIL and ASPIRIN [ACETYLSALICYLIC ACID] for Blood pressure management, CYCLOBENZAPRINE for Muscle relaxation.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Felt tired). On 04-Apr-2021, FATIGUE (Felt tired) had resolved.            No treatment information was provided.   This case was linked to MOD-2022-538649, MOD-2022-538657 (Patient Link).
Tenderness in her left arm; Lymph node swelling in her neck on her left side; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in her left arm) and LYMPHADENOPATHY (Lymph node swelling in her neck on her left side) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced TENDERNESS (Tenderness in her left arm) and LYMPHADENOPATHY (Lymph node swelling in her neck on her left side). At the time of the report, TENDERNESS (Tenderness in her left arm) and LYMPHADENOPATHY (Lymph node swelling in her neck on her left side) outcome was unknown.            The patient's medical history was not provided.  No relevant concomitant medications were reported. Treatment information included Tylenol.
Breakthrough COVID + 8/19/2021 requiring hospitalization for acute respiratory failure, sepsis
Bells palsy occurred 2 days after Pfizer vaccine. Left facial droop and difficulty closing left eye, no other neurologic deficits, no other recent viral illness.
Headache, elevated blood pressure, chills & shivering, right arm & back pains,
Pt recvd vax on 22JUN92 & shortly p/vax pt devel pruritic, urticarial rash over arms, hands, legs, abdo & back; lab eval revealed CBC was nl;
Information has been received from a consumer and a school nurse concerning 41 child patients who in approximately 1995 were each vaccinated with a dose of varicella virus vaccine live. In approximately 2003, the patients developed mild cases of chickenpox.  Most of the children were in the first grade and had been vaccinated at their private pediatrician's offices in the area. The reporter noted that her elementary school was the only one out of six in the area that has experienced a chickenpox outbreak. The reporter notified the elementary school parents of the outbreak. Follow up information from the nurse indicated that 13 of the reported 41 patients were not previously vaccinated with a dose of varicella virus vaccine live and all of the cases of chickenpox have recovered. One of the previously vaccinated patients was a 6 year old patient who on 19JUN1998 was vaccinated with a dose of varicella virus vaccine live. On 18MAR2003, the patient developed chickenpox. The previously vaccinated patients included two siblings in elementary school who were vaccinated by the same pediatrician and subsequently developed mild outbreaks of chickenpox. The other patients that developed chickenpox post vaccination with varicella virus vaccine live were also identified.  Additional information is not expected.
Patient is having pain in her left arm, left buttock, left leg, and left foot. This pain began 1 day after receiving the initial dose of the Moderna Vaccine.
first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose).    No concomitant product was reported. It was reported that patient received the first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose. Reporter enquired if there was need to restart the series. No treatment information was reported.
1-Extreme weakness- inability to walk unassisted- still ongoing for 6th day, needs walker or other people; cannot shower alone; cannot fix own food or pour glass of milk 2-Nausea- all 6 days, and unable to eat on day 2; has taken small amt of food when able; Zofran given 3-Pounding, blinding headache- ongoing; treated with Tylenol, Alleve; low lighting; no reading or concentrating 4-Extreme Sleepiness- inability to stay awake for more than 2-3 hours at a time for 5 days,  5-Hot and Cold flashes; no fever; adding or subtracting blankets and clothing, ongoing
After these vaccines he developed blood diarrhea for a few days. Mom reports after 2 and 4 month vaccines he developed mucoid foul stools for weeks. Allergist referral being done.
Adverse event included pain at injection site, chills, fever 100 (only lasting two days), muscle aches, fatigue, lasted five days and then returned, with severe muscle aches and headache and fatigue two days later  then resolved after two days  and returned again seven days later with sore throat, achiness, headache and fatigue.
patient came in for 2nd covid vaccine administration; mom did not have card with her and administered vaccine and realized patient was 1 week early for 2nd vaccine; pt waited for 15 minutes in office and did not complain of any adverse effects.  Mom notified and informed that patient does not need 3rd vaccine;
Received 3 influenza vaccines (1988,1994, 1997 dates unknown). 1988 mild pruritis; 1994 pruritic hives to body; 1997 resp distress, red hives, fatigue, wheezing, difficulty breathing tx'd with pred, inhaler, antibiotic after dx changed to pneumonia. Symptoms: Dyspnea (shortness of breath), Wheezing, Hives, Pruritus.
This spontaneous report as received from a 67 year old female patient refers to herself. Information about concurrent conditions, concomitant medication and medical history was not provided. On 09-NOV-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot#, dose, route and frequency were not provided). On 12-NOV-2014, the patient developed a cold and cough after receiving ZOSTAVAX. The patient did not seek for medical attention. The outcome of events was reported as not recovered. Additional information is not expected because no consent to contact physician.
bumpy; moderna arm covid rash; itchy; turned a little bit red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (bumpy), VACCINATION SITE RASH (moderna arm covid rash), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (turned a little bit red) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE NODULE (bumpy), VACCINATION SITE RASH (moderna arm covid rash), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (turned a little bit red). At the time of the report, VACCINATION SITE NODULE (bumpy), VACCINATION SITE RASH (moderna arm covid rash), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (turned a little bit red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication not provided.
fever; dizziness; headache; muscle pain; joint pain; chills; sweating; nausea; I feel horrible/I feel like I was hit by a bus and I am still being dragged; Injection site pain as soon as I got the second dose; tiredness; weakness; This is a spontaneous report from a contactable Other healthcare professional (patient). A 29-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9262), via an unspecified route of administration on 04Feb2021, administered into left arm as 2nd dose, single for COVID-19 immunization at Public Health Clinic. The patient medical history and concomitant medications were not reported. patient was not diagnosed with COVID. Patient had no allergies. The patient previously had received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL8982), via an unspecified route of administration on 14Jan2021 into left arm for COVID-19 immunization at public health clinic. On 04Feb2021, the patient experienced Injection site pain as soon as she got the second dose. Followed by tiredness and weakness. On 05Feb2021 (next day), had a fever, dizziness, headache, muscle pain, joint pain, chills, sweating, and nausea, she feels horrible. Feel like she was hit by a bus and still being dragged. No treatment was given for the events. Patient did not receive any other vaccine in four weeks. Prior the vaccination. On 21Jan2021, the patient underwent lab tests which included sars-cov-2 test: negative. The clinical outcome of the Injection site pain, tiredness and weakness, fever, dizziness, headache, muscle pain, joint pain, chills, sweating, and nausea, she feels horrible were not recovered.  Follow-up attempts are completed. No further information is expected.
Fever chills muscle aches confused foggy mind, aches, weird taste vivid dreams mild ear ache total exhaustion debilitating exhausted since 8 hrs after 2nd shot. 1st dose only mild soreness at injection site but 2nd dose is awful. On 3rd day getting worse as is my partner. Both literally bedridden.
Initial physician report received via Health Authority (AT-BASGAGES-101840) received on 12 Nov 2010: This patient was vaccinated with MENVEO (batch number 100014) intramuscularly on 13 Oct 2010. On the same day, the patient experienced fever, headache and vaccination site swelling. The reporter assessed the case as serious (seriousness as other). On an unspecified date, the patient completely recovered from all the events.
Received Pfizer vaccine on 2-3-2021, checked blood pressure on Saturday 2-6-2021, she noticed her blood pressure was a bit elevated. Later 2/8/2021 went to ER due to home systolic BP in 200s, no other symptoms reported. Discharged from ER same day, reports was told by hospital staff possibly from recent vaccine. Did not have labs or other testing while at ER she states. Today 2/9/2021 blood pressure improving 150s systolic, pending to restart her blood pressure medication.
Patient reported tenderness and pain at site of injection which radiated down the right arm and up to the shoulder and neck. Pain is not sharp and there is no numbness or tingling. Patient can raise arm slightly. The injection site was not red or swollen. Patient was able to work today at her job.
Itching, coughing, hives, SOB, redness over influenza injection site, Benadryl IV, Solumedrol IV, Epinephrine, Pepcid IV, MS IV. Toprol.  12/04/2007 MR received for DOS 11/14-16/2007 with D/C Dx: Anaphylactic reaction to Influenza A immunization. Chest pain, etiology uncertain, possibly related to the reaction.  Post-menopausal.   Pt presented to ER with a reaction to the flu shot which consisted of  throat irritation, cough, urticaria, swelling, itching and respiratory compromise. Treated with epi, Benadryl, steroids and O2 with gradual improvement.  However, pt developed L-side chest pressure and pain which was not responsive to morphine.  Admitted to ICU for observation and eval. Pt had several recurrances during hospital stay. Improvement noted with Labetalol and po beta-blockers.
Patient reports achiness in her joints that she has never had before, since the onset of the Shingrix series.
In July I went to an Urgent Care to obtain treatment (Tobramycin drops) for a Stye in my right eye.  I also needed to have two root canal procedures in August for an abscessed tooth that seems to have started in early May.  I was contacted by V-safe and encouraged to submit this report.
Nurse warned me to take pain medication after the injection, which I did - one ibuprofen 200 mg and one tylenol 500 mg. I didn't really take this seriously as I don't normally take pain medication even for a dtap or similar vaccine which typically causes soreness at the injection site. In this case, not only was there soreness at the injection site 4 hours later, but throughout the next day, the pain in my left arm was 4-5 inches around the injection site - nearly down to my elbow. This pain didn't completely diminish for at least a week. I also had body aches the following day as well as the day after in my bones and joints. This was very uncomfortable and made it difficult to carry out my duties at work.  There was also a large bruise at the injection site - a white spot surrounded by a livid bruise around that. People who saw it found it startling; I also took pictures. Now two weeks later this bruise is not completely gone.  I have traveled widely overseas and had many vaccinations, including typhoid. This is the worst vaccine experience I've had. I have warned my elderly parents to never take this vaccine.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 23-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) (lot # L035105, expiration date 14-MAY-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 24 hours with the highest recorded temperature of 30.8 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Patient arrived at clinic with parents-for well child check and establishment with healthcare provider-Questions and concerns relating to vaccines discussed- Mom requested that Hep B be administered to patient.
a patient received a dose of Pentacel vaccine that had been at a temperature of greater than 77 F for 12 hours/ No AE; Initial information received on 17-May-2021 regarding an unsolicited valid non-serious case received from a Nurse educator via physician via Medical Information (Reference number- 00603828).  This case involves a five months old female patient who received a 0.5 ml third dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] that had been at a temperature of greater than 77 f for 12 hours lot UJ416AA, expiry date: 22-MAR-2022, frequency: once, strength: standard via intramuscular route in the left thigh (left quadriceps) on 15-May-2021for prophylactic vaccination (product storage error).  The patient's medical history, medical treatments, vaccinations and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) via oral route for prophylactic vaccination respectively.  It was an actual medication error due to incorrect product storage (latency same day).  Potential Product Technique Complain: No.  At the time of report no adverse event was reported.  No causality not reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt rcvd vax; pt exp join pain & swelling on fingers, knees & shoulders; difficulty lifting arm; muscles aches; pt had early degenerative joint disease; pt taken to MD;
Hands became pruritic and small bumps formed on them, headache, fatigue approx. 1 hour after receiving the Hepatitis B vaccine
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated subcutaneous in left arm with 0.65 ml expired ZOSTAVAX (lot # 671004/0729AA, expiration date 17-AUG-2012) on 07-SEP-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effects reported. It was unspecified if the patient had sought medical attention. Additional information has been requested. This is one of the several reports received from the same source.
30 minutes after injection, child c/o needed to sit down.  Stated head "feels funny".  Child laid on exam table.  Remained conscious, alert, nonmotensive, skin warm/dry.  Strong palpable pulses BUE.  Rested x15 min, then left office with mother.  F/u with mother late afternoon, child was fine, exhibiting normal behavior.